“I’ve been a mechanic my whole life — I can’t do anything hands on anymore,” said Norris, who stopped taking Mounjaro around July 2024 but still has significantly impaired vision.
He now mostly does administrative work from a computer and believes the risk of the medications, particularly at higher doses, isn’t worth it.
While it’s unclear how many people on these drugs are experiencing vision issues, Norris’s attorney, Robert King, said his firm alone has received “hundreds” of GLP-1 medication and vision-loss related cases.